Steroid-Dependency in Posner-Schlossman Syndrome: A Suggested Topical 2% Ganciclovir and Gradual Decrement of Topical Steroid Combination Therapy from Shanghai PSS Study

References

• Megaw R, Agarwal PK. Posner-Schlossman syndrome. Surv Ophthalmol. 2017;62(3):277–285. doi:10.1016/j.survophthal.2016.12.005.
   PubMed Web of Science ®Google Scholar
• Woo JH, Lim WK, Ho SL, Teoh SC. Characteristics of cytomegalovirus uveitis in immunocompetent patients. Ocul Immunol Inflamm. 2015;23(5):378–383. doi:10.3109/09273948.2014.950384.
   PubMed Web of Science ®Google Scholar
• Jap A, Sivakumar M, Chee SP. Is Posner Schlossman syndrome benign? Ophthalmology. 2001;108(5):913–918. doi:10.1016/S0161-6420(01)00551-6.
   PubMed Web of Science ®Google Scholar
• Kim JH, Lee JY, Choi JA. Long-term prognosis for glaucoma in patients with Posner-Schlossman syndrome. Graefes Arch Clin Exp Ophthalmol. 2021;259(12):3757–3767. doi:10.1007/s00417-021-05291-0.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Sun C, Zhang X, Shentu X. Ptosis induced by topical steroid eye drops: two cases reports. Medicine. 2017;96(51):e9288. doi:10.1097/MD.0000000000009288.
   PubMed Web of Science ®Google Scholar
• Gaballa SA, Kompella UB, Elgarhy O, et al. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Deliv Transl Res. 2021;11(3):866–893. doi:10.1007/s13346-020-00843-z.
   PubMed Web of Science ®Google Scholar
• Tripathi RC, Parapuram SK, Tripathi BJ, Zhong Y, Chalam KV. Corticosteroids and glaucoma risk. Drugs & Aging. 1999;15(6):439–450. doi:10.2165/00002512-199915060-00004.
   PubMed Web of Science ®Google Scholar
• Bilgihan K, Gurelik G, Akata F, Hasanreisoglu B. Fluorometholone-induced cataract after photorefractive keratectomy. Ophthalmologica. 1997;211(6):394–396. doi:10.1159/000310839.
   PubMed Web of Science ®Google Scholar
• Bloch-Michel E, Dussaix E, Cerqueti P, Patarin D. Possible role of cytomegalovirus infection in the etiology of the Posner-Schlossmann syndrome. Int Ophthalmol. 1987;11(2):95–96. doi:10.1007/BF00136737.
   PubMed Web of Science ®Google Scholar
• Hedayatfar A, Chee SP. Posner-Schlossman syndrome associated with cytomegalovirus infection: a case series from a non-endemic area. Int Ophthalmol. 2014;34(5):1123–1129. doi:10.1007/s10792-014-9928-6.
   PubMed Web of Science ®Google Scholar
• Zhai RY, Xu H, Kong XM, Wang ZJ. Effect of 2% ganciclovir eye drops on cytomegalovirus positive Posner-Schlossman syndrome. Zhonghua Yan Ke Za Zhi. 2018;54(11):833–838. doi:10.3760/cma.j.issn.0412-4081.2018.11.007.
   PubMedGoogle Scholar
• Wong JX, Agrawal R, Wong EP, Teoh SC. Efficacy and safety of topical ganciclovir in the management of cytomegalovirus (CMV)-related anterior uveitis. J Ophthalmic Inflamm Infect. 2016;6(1):10. doi:10.1186/s12348-016-0078-z.
   PubMedGoogle Scholar
• Antoun J, Willermain F, Makhoul D, Motulsky E, Caspers L, Relvas LJ. Topical Ganciclovir in cytomegalovirus anterior uveitis. J Ocul Pharmacol Ther. 2017;33(4):313–318. doi:10.1089/jop.2016.0138.
   PubMed Web of Science ®Google Scholar
• Sheng Q, Zhai R, Fan X, Kong X. The analysis of dynamic changes and prognosis of Posner-Schlossman syndrome with cytomegalovirus infection and antiviral therapy. J Ophthalmol. 2021;2021:6687929. doi:10.1155/2021/6687929.
   PubMed Web of Science ®Google Scholar
• Sheng Q, Zhai R, Sun Y, Fan X, Ying Y, Kong X. Iris abnormalities may influence the efficacy and filtration strategies of Posner–Schlossman syndrome: a retrospective study involving trabeculectomy, ExPRESS and Ahmed valve implants. Graefes Arch Clin Exp Ophthalmol. 2022;261(3):791–801. doi:10.1007/s00417-022-05865-6.
   PubMed Web of Science ®Google Scholar
• Yan X, Li M, Chen W, Chen Z. Quantification of iris atrophy by swept-source optical coherence tomography in Posner–Schlossman Syndrome. J Clin Med. 2022;11(21):6484. doi:10.3390/jcm11216484.
   PubMed Web of Science ®Google Scholar
• Fan X, Li Z, Zhai R, Sheng Q, Kong X. Clinical characteristics of virus-related uveitic secondary glaucoma: focus on cytomegalovirus and varicella zoster virus. BMC Ophthalmol. 2022;22(1):130. doi:10.1186/s12886-022-02348-4.
   PubMed Web of Science ®Google Scholar
• Maruyama K, Maruyama Y, Sugita S, et al. Characteristics of cases needing advanced treatment for intractable Posner-Schlossman syndrome. BMC Ophthalmol. 2017;17(1):45. doi:10.1186/s12886-017-0438-y.
   PubMedGoogle Scholar
• Keorochana N, Treesit I, Funarunart P. Characteristics and clinical outcomes of hypertensive anterior uveitis. Ocul Immunol Inflamm. 2020;28(4):538–548. doi:10.1080/09273948.2019.1587471.
   PubMed Web of Science ®Google Scholar
• Murata K, Ishida K, Ozawa K, Sawada A, Mochizuki K, Yamamoto T. The characteristics of Posner-Schlossman syndrome: a comparison in the surgical outcome between cytomegalovirus-positive and cytomegalovirus-negative patients. Medicine. 2019;98(48):e18123. doi:10.1097/MD.0000000000018123.
   PubMed Web of Science ®Google Scholar
• Sheng Q, Zhai R, Fan X, Kong X. 2% Ganciclovir eye drops control Posner-Schlossman syndrome relapses with/without cytomegalovirus intraocular reactivation. Front Med (Lausanne). 2022;9:848820. doi:10.3389/fmed.2022.848820.
   PubMed Web of Science ®Google Scholar
• Su CC, Hu FR, Wang TH, et al. Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy. Am J Ophthalmol. 2014;158(5):1024–31.e2. doi:10.1016/j.ajo.2014.08.007.
   PubMed Web of Science ®Google Scholar
• Accorinti M, Gilardi M, Pirraglia MP, et al. Cytomegalovirus anterior uveitis: long-term follow-up of immunocompetent patients. Graefes Arch Clin Exp Ophthalmol. 2014;252(11):1817–1824. doi:10.1007/s00417-014-2782-4.
   PubMed Web of Science ®Google Scholar
• Zhou J, Lin X, Shang H, et al. Ganciclovir attenuates the onset and progression of experimental autoimmune uveitis by inhibiting infiltration of Th17 and inflammatory cells into the retina. Biochem Pharmacol. 2022;197:114917.25. doi:10.1016/j.bcp.2022.114917.
   PubMed Web of Science ®Google Scholar
• Kanda T, Shibata M, Taguchi M, Ishikawa S, Harimoto K, Takeuchi M. Prevalence and aetiology of ocular hypertension in acute and chronic uveitis. Br J Ophthalmol. 2014;98(7):932–936. doi:10.1136/bjophthalmol-2013-304416.
   Google Scholar